Ladenburg Thalmann Financial Services’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $4K | Hold |
1,385
| – | – | ﹤0.01% | 4850 |
|
|
2019
Q3 | $5K | Hold |
1,385
| – | – | ﹤0.01% | 4679 |
|
|
2019
Q2 | $6K | Buy |
1,385
+385
| +39% | +$1.67K | ﹤0.01% | 4635 |
|
|
2019
Q1 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 4654 |
|
|
2018
Q4 | $3K | Buy |
+1,000
| New | +$3K | ﹤0.01% | 4765 |
|
|
2018
Q3 | – | Sell |
-2,000
| Closed | -$9K | – | 5203 |
|
|
2018
Q2 | $9K | Hold |
2,000
| – | – | ﹤0.01% | 4295 |
|
|
2018
Q1 | $9K | Hold |
2,000
| – | – | ﹤0.01% | 4295 |
|
|
2017
Q4 | $7K | Hold |
2,000
| – | – | ﹤0.01% | 4367 |
|
|
2017
Q3 | $4K | Buy |
+2,000
| New | +$4K | ﹤0.01% | 4470 |
|
|
2016
Q4 | – | Sell |
-708
| Closed | -$1K | – | 4871 |
|
|
2016
Q3 | $1K | Hold |
708
| – | – | ﹤0.01% | 4611 |
|
|
2016
Q2 | $1K | Hold |
708
| – | – | ﹤0.01% | 4558 |
|
|
2016
Q1 | $1K | Hold |
708
| – | – | ﹤0.01% | 4510 |
|
|
2015
Q4 | $1K | Hold |
708
| – | – | ﹤0.01% | 4503 |
|
|
2015
Q3 | $2K | Hold |
708
| – | – | ﹤0.01% | 4254 |
|
|
2015
Q2 | $2K | Sell |
708
-119
| -14% | -$336 | ﹤0.01% | 4340 |
|
|
2015
Q1 | $3K | Hold |
827
| – | – | ﹤0.01% | 4157 |
|
|
2014
Q4 | $3K | Buy |
827
+119
| +17% | +$432 | ﹤0.01% | 3914 |
|
|
2014
Q3 | $4K | Buy |
708
+208
| +42% | +$1.18K | ﹤0.01% | 3479 |
|
|
2014
Q2 | $7K | Hold |
500
| – | – | ﹤0.01% | 3237 |
|
|
2014
Q1 | $8K | Hold |
500
| – | – | ﹤0.01% | 3064 |
|
|
2013
Q4 | $4K | Sell |
500
-26,072
| -98% | -$209K | ﹤0.01% | 3317 |
|
|
2013
Q3 | $198K | Buy |
26,572
+25,572
| +2,557% | +$191K | 0.01% | 1013 |
|
|
2013
Q2 | $4K | Buy |
+1,000
| New | +$4K | ﹤0.01% | 3131 |
|